{
    "root": "36209e13-f845-d59b-e063-6394a90a5b6d",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Terazosin",
    "value": "20250527",
    "ingredients": [
        {
            "name": "GELATIN",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "TERAZOSIN HYDROCHLORIDE",
            "code": "D32S14F082",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9445"
        }
    ],
    "indications": {
        "text": "terazosin capsules indicated treatment symptomatic benign prostatic hyperplasia ( bph ) . rapid response , approximately 70 % patients experiencing increase urinary flow improvement symptoms bph treated terazosin capsules . long-term effects terazosin capsules incidence surgery , acute urinary obstruction complications bph yet determined . terazosin capsules also indicated treatment hypertension . terazosin capsules used alone combination antihypertensive agents diuretics beta-adrenergic blocking agents .",
        "doid_entities": [
            {
                "text": "urinary obstruction (DOID:5200)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5200"
            },
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "acute urinary obstruction",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_435365"
            }
        ]
    },
    "contraindications": {
        "text": "terazosin capsules discontinued several days , therapy reinstituted using initial dosing regimen .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "2 mg terazosin capsules , usp available size 3 ivory opaque capsules printed `` tl 384 `` axially black ink body cap . ndc : 70518-0074-00 ndc : 70518-0074-01 packaging : 30 1 blister pack packaging : 30 1 blister pack dispense tight , light-resistant container defined usp . recommended storage : store 20 25\u00b0c ( 68 77\u00b0f ) [ usp controlled room temperature ] . protect light moisture . rx repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "terazosin capsules contraindicated patients known hypersensitive terazosin hydrochloride .",
    "indications_original": "Terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). There is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of BPH when treated with terazosin capsules. The long-term effects of terazosin capsules on the incidence of surgery, acute urinary obstruction or other complications of BPH are yet to be determined.\n                  Terazosin capsules are also indicated for the treatment of hypertension. Terazosin capsules can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents.",
    "contraindications_original": "If terazosin capsules administration is discontinued for several days, therapy should be reinstituted using the initial dosing regimen.",
    "warningsAndPrecautions_original": "2 mg Terazosin Capsules, USP are available as Size 3 ivory opaque capsules printed \"TL 384\" axially in black ink on body and cap.\n                  NDC: 70518-0074-00\n                  NDC: 70518-0074-01\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  \n                  Dispense in a tight, light-resistant container as defined in the USP.\n                  \n                  Recommended storage: Store at 20 to 25\u00b0C (68 to 77\u00b0F) [see USP Controlled Room Temperature].\n                  Protect from light and moisture.\n                  Rx only\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Terazosin capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.",
    "drug": [
        {
            "name": "Terazosin",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9445"
        }
    ]
}